These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35339066)

  • 1. Call for correction: Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Hagiya H; Otsuka Y; Otsuka F
    J Neurol Sci; 2022 May; 436():120232. PubMed ID: 35339066
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-COVID: neurological manifestations and management.
    Williams S; Wynford-Thomas R; Robertson NP
    J Neurol; 2021 Dec; 268(12):4915-4917. PubMed ID: 34674007
    [No Abstract]   [Full Text] [Related]  

  • 3. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update 2021: COVID-19 from the perspective of neurology].
    Simon OJ; Menzler K; Timmermann L
    Dtsch Med Wochenschr; 2021 Jul; 146(13-14):918-923. PubMed ID: 34256409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological and neuroimaging tools to evaluate neurological symptoms, manifestations, and complications in patients with long COVID-19.
    Luvizutto GJ; Bazan R
    Neurol Neurochir Pol; 2023; 57(1):8-10. PubMed ID: 36515147
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging Knowledge of the Neurobiology of COVID-19.
    Butler M; Cross B; Hafeez D; Lim MF; Morrin H; Rengasamy ER; Pollak T; Nicholson TR
    Psychiatr Clin North Am; 2022 Mar; 45(1):29-43. PubMed ID: 35219440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.
    Beghi E; Giussani G; Westenberg E; Allegri R; Garcia-Azorin D; Guekht A; Frontera J; Kivipelto M; Mangialasche F; Mukaetova-Ladinska EB; Prasad K; Chowdhary N; Winkler AS
    J Neurol; 2022 May; 269(5):2265-2274. PubMed ID: 34674005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological complications of SARS-CoV-2 infection in children can be acute or post-acute.
    Mehri S; Finsterer J
    J Formos Med Assoc; 2024 Jul; 123(7):821-822. PubMed ID: 38627191
    [No Abstract]   [Full Text] [Related]  

  • 9. Nervous system consequences of COVID-19.
    Spudich S; Nath A
    Science; 2022 Jan; 375(6578):267-269. PubMed ID: 35050660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID: understanding the neurological effects.
    The Lancet Neurology
    Lancet Neurol; 2021 Apr; 20(4):247. PubMed ID: 33743226
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.
    Jesuthasan A; Massey F; Manji H; Zandi MS; Wiethoff S
    J Neurol Sci; 2021 Sep; 428():117608. PubMed ID: 34391037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID: Does SARS-CoV-2 induce lingering brain lesions?
    Hugon J
    Eur J Neurol; 2023 May; 30(5):1165-1166. PubMed ID: 36802122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic long-COVID syndrome: A protracted COVID-19 illness with neurological dysfunctions.
    Baig AM
    CNS Neurosci Ther; 2021 Dec; 27(12):1433-1436. PubMed ID: 34626096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor: "What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?".
    Pan Y; Zhao S; Chen F
    World Neurosurg; 2020 Dec; 144():310-311. PubMed ID: 33227857
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System.
    Fajloun Z; Kovacic H; Annweiler C; Wu Y; Cao Z; Sabatier JM
    Infect Disord Drug Targets; 2022; 22(5):e060422203203. PubMed ID: 35388764
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-COVID 19 neurological syndrome: Are we facing a neuropsychiatric phenotype?
    Rubiano-Buitrago JD; Rahiran-Ramírez AF; Peña-Vargas DM; Paez-Rincon LA; Lozada-Martinez ID
    J Clin Neurosci; 2022 Mar; 97():106-107. PubMed ID: 35077946
    [No Abstract]   [Full Text] [Related]  

  • 17. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.
    Llach CD; Vieta E
    Eur Neuropsychopharmacol; 2021 Aug; 49():119-121. PubMed ID: 33992951
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.